Hyphens Pharma subsidiary granted e-pharmacy license

It aims to support medical clinics with e-pharmacy service.

The Health Sciences Authority has granted an e-pharmacy license to Pan-Malayan Pharmaceuticals Pte Ltd, a subsidiary of specialty pharmaceutical and consumer healthcare group Hyphens Pharma International Limited, for its WellAway Pharmacy.

WellAway Pharmacy will use the medical and logistical expertise of Pan-Malayan and work closely with medical clinics in Singapore to provide reliable and convenient medication delivery service to consumers.

Hyphens Pharma said the license will not have a material effect on the net tangible assets or earnings per share of the group for the financial year ending 31 December 2021.

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia